Close
Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
Show source BACK TO LIST

Laboratory Report

Patient
Name: Palermo, Degna
DOB: 24-AUG-1972 (Age: 53)
Gender: female
Address:
Avda. Generalísimo 54
31860 Irurtzun (Spain)
ID: 6953-191487-2
Report
Date: 14-FEB-2024
Laboratory
Requested by
Clínica Psiquiátrica Padre Menni
31014 Pamplona (Spain)
Specimen
Collected: 13-FEB-2024

Chemistry

Test 13 Feb 2024 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.2 H 4 - 6 %
Glucose [Mass/volume] in Blood 69.9 L 70 - 99 mg/dL
Urea nitrogen [Mass/volume] in Blood 11.4 7 - 25 mg/dL
Creatinine [Mass/volume] in Blood 0.7 0.5 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 9.5 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 136.5 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 3.8 3.5 - 5 mmol/L
Chloride [Moles/volume] in Blood 107.6 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 20.9 L 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 154.5 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 131.1 35 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 78.6 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 49.6 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows a mildly elevated HbA1c (6.2%) indicating impaired glucose regulation or possible early diabetes, with a slightly low fasting glucose. Electrolytes and renal function are within normal limits, except for mildly low total CO₂, which may suggest mild metabolic acidosis. Lipid profile is within target ranges. No acute abnormalities detected, but recommend follow-up for glycemic control and assessment of acid-base status.